Sign in
Taking people in SwedenPhase 1/2

Tracking spinal fluid flow in the brain with MRI contrast dye

Tests Gadovist given in the spinal canal, tracked by MRI, in adults.

Key facts

Who runs it
Region Vaesterbotten
Where
Umea, SwedenSee the site
Registry title
MRI contrast agent in the spinal canal to investigate transportation of the cerebrospinal fluid in the brain.
Status
Recruiting
Phase
Phase 1/2
People taking part
135 people, planned
Started
13 Jan 2025
Expected to end
31 Dec 2030
Type of study
Interventional
Record updated
23 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people being checked for suspected idiopathic normal pressure hydrocephalus at Umeå University hospital, people with Alzheimer's disease, and healthy volunteers. They get a contrast agent (Gadovist) into the spinal canal, then repeated MRI scans to see how the fluid around the brain moves.

Age
18 Years and older. People with suspected normal pressure hydrocephalus must be 65 or older. People with Alzheimer's disease and healthy volunteers must be 55 years or older.
Sex
All sexes can join.
Disease stage
Suspected idiopathic normal pressure hydrocephalus (fluid build-up in the brain with no known cause), or Alzheimer's disease. Healthy volunteers can also join.
Earlier treatment
People who have had a test with a gadolinium contrast agent before cannot join. People now taking blood thinners cannot join.
Biomarker or test result
A memory test score (MMSE) of 20 or higher is needed.

Main reasons for not taking part

  • Liver failure or reduced kidney function (shown by a blood test at admission)
  • Cannot understand the instructions needed to give consent
  • Known allergies that rule out the contrast agent, or reasons you cannot have an MRI
  • Seizures happen easily, or a history of bronchial asthma
  • Current treatment with blood thinners, or an earlier test with gadolinium contrast

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Patients investigated for suspected idiopathic normal pressure hydrocephalus at Umeå University hospital
  • Patients with Alzheimers disease
  • Healthy controls

Who cannot take part

  • Current treatment with anticoagulation medication
  • Previous investigation with gadolinium contrast medium
  • Liver failure
  • known contradicting allergies
  • Renal impairment (as deffined by blood test at admission)
  • Low threshold for seizures
  • History of bronchial asthma
  • Age <65 for INPH. Age <55 years for AD and HC
  • Mini mental state examination (MMSE) < 20
  • Not able to understand instructions needed for informed concent
  • Known contraindications for magnetic reconance imaging

Where in Sweden

  • Region VaesterbottenUmea, SwedenTaking people

About the trial

What the trial wants to find out

To quantify the distribution and rate of elimination of the contrast agent as assessed by repeated MRI in humans. We will also document any adverse events related to the administration of Gadovist

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Intrathecal contrast-enhanced MRI for investigation of cerebrospinal fluid transportation
Plain-language title
Tracking spinal fluid flow in the brain with MRI contrast dyeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
23 July 2026